Pilomatrixoma: genes and variants
Explore variant evidence for Pilomatrixoma across 2 analyzed proteins (CTNNB1, MUTYH). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 2 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Pilomatrixoma
CTNNB1: Catenin beta-1
It links cadherins to the cytoskeleton at adherens junctions and, when stabilized by Wnt signaling, enters the nucleus to regulate transcription. Activating somatic variants drive many cancers, while germline loss-of-function variants cause CTNNB1 neurodevelopmental disorder.
8 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in CTNNB1 have source records linked to Pilomatrixoma. Association strength is not clinical gene validity.
MUTYH: Adenine DNA glycosylase
It removes adenines incorrectly paired with oxidized guanine, preventing characteristic G:C-to-T:A mutations during base-excision repair. Biallelic loss-of-function variants cause MUTYH-associated polyposis and substantially increase colorectal-cancer risk.
1 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in MUTYH have source records linked to Pilomatrixoma. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Pilomatrixoma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CTNNB1 T41A | 41 | Pathogenic / likely pathogenic (★★) | |
| MUTYH R179C | 179 | Pathogenic / likely pathogenic (★★) | |
| CTNNB1 D32G | 32 | Pathogenic / likely pathogenic | |
| CTNNB1 D32Y | 32 | Pathogenic / likely pathogenic | |
| CTNNB1 S33F | 33 | Pathogenic / likely pathogenic | |
| CTNNB1 S33Y | 33 | Pathogenic / likely pathogenic | |
| CTNNB1 S37C | 37 | Pathogenic / likely pathogenic | |
| CTNNB1 S37F | 37 | Pathogenic / likely pathogenic | |
| CTNNB1 G34E | 34 | Pathogenic / likely pathogenic |
Which prediction tools work for Pilomatrixoma
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 100 out of 100
- EVE: 100 out of 100
- PolyPhen-2: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 94 out of 100
- CATVariant: 82 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 80 out of 100
- MetaSVM: 68 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 62 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 45 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Severe intellectual disability-progressive spastic diplegia syndrome also has ClinVar records linked to CTNNB1 variants; they fall mostly in different places as the Pilomatrixoma variants (5 pathogenic / likely pathogenic).
- Familial adenomatous polyposis also has ClinVar records linked to MUTYH variants; they fall mostly in different places as the Pilomatrixoma variants (27 pathogenic / likely pathogenic).
- Gastric cancer also has ClinVar records linked to MUTYH variants; they fall mostly in different places as the Pilomatrixoma variants (11 pathogenic / likely pathogenic).
Diseases related to Pilomatrixoma
- Colorectal cancer, also linked to CTNNB1 and MUTYH
- Colon carcinoma, also linked to CTNNB1 and MUTYH
- Ovarian cancer, also linked to CTNNB1
- Familial adenomatous polyposis, also linked to MUTYH
- Gastric cancer, also linked to MUTYH
- Urinary bladder cancer, also linked to CTNNB1
- Ovarian neoplasm, also linked to CTNNB1
- Hepatocellular carcinoma, also linked to CTNNB1
- Severe intellectual disability-progressive spastic diplegia syndrome, also linked to CTNNB1
- Medulloblastoma, also linked to CTNNB1
- Autosomal dominant polycystic liver disease, also linked to CTNNB1
- Desmoid disease, hereditary, also linked to CTNNB1
Frequently asked questions
Which genes have records linked to Pilomatrixoma?
This view contains 2 analyzed proteins: CTNNB1, MUTYH. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 20 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center